KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors - nejm.org
- KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors nejm.org
- Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation - study Yahoo News
- Durable responses seen with Amgen's KRAS-blocking cancer drug STAT
- ESMO: Amgen's KRAS drug tackles 32% of lung cancers—and this is just the beginning FierceBiotech
- View Full Coverage on Google News